Improving Access and Affordability of Adult Hearing Healthcare
University of Alabama, Tuscaloosa · with University of Alabama at Birmingham · NCT04671381
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 40+ · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 210
- US sites recruiting
- 1
- Study start
- January 1, 2021
- Record last updated
- October 30, 2024
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
This project will address quality of care issues associated with hearing loss in adults who have mild-to-moderate hearing loss and who have no access to hearing healthcare. Through the use of three different interventions involving over-the-counter hearing aids, it will lead to options that will increase access and affordability of hearing healthcare for adults with mild-to-moderate hearing loss.
Being studied: Hearing Evaluation; Over-the-Counter Hearing Aid (OTC HA) Fitting and Orientation; Four Weeks of Aural Rehabilitation; Provision of Over-the-Counter Hearing Aids
Conditions: Hearing Loss
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Mild-to-moderate hearing loss
- Live in West Central or South Alabama
- 40 years of age or older
Exclusion Criteria
- Medical conditions resulting in severe cognitive impairment (e.g., stroke, head injury, senile dementia or Alzheimer's disease)
Recruiting US locations
The University of Alabama
Tuscaloosa, AL 35487
Site contact: Marcia J Hay-McCutchoen, PhD · 205-348-4572 · mhaymccu@ua.edu
Study contacts (from the official record)
- Marcia J Hay-McCutcheon, PhD · 205-348-4572 · mhaymccu@ua.edu
Similar studies in Alabama
All healthy volunteers studies in Alabama →- RecruitingHealthy volunteersPhase 1/Phase 2
A Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell Disease
Novartis Pharmaceuticals
- Location
- Birmingham, AL + 7 other US sites
- Eligibility basics
- Ages 12–55
- RecruitingHealthy volunteersPhase 1/Phase 2
Phase 1/2 Study of Respiratory Syncytial Virus and Human Metapneumovirus (RSV+HMPV) Vaccine Candidate in Adults 60 Years of Age and Older
Sanofi
- Location
- Gadsden, AL + 49 other US sites
- Eligibility basics
- Ages 60+
- RecruitingHealthy volunteersPhase 1
First-in-Human Trial to Assess REGN20423 in Healthy Adult Participants and Adult Participants With Atopic Dermatitis
Regeneron Pharmaceuticals
- Location
- Birmingham, AL + 5 other US sites
- Eligibility basics
- Ages 18–65
- RecruitingHealthy volunteersPhase 1
A Study of Ulonivirine (MK-8507) and Methadone in Healthy Volunteers (MK-8507-019)
Merck Sharp & Dohme LLC
- Location
- Anniston, AL
- Eligibility basics
- Ages 18–65